Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Operating Expenses (2016 - 2017)

Historic Other Operating Expenses for KalVista Pharmaceuticals (KALV) over the last 4 years, with Q1 2017 value amounting to -$9.6 million.

  • KalVista Pharmaceuticals' Other Operating Expenses changed N/A to -$9.6 million in Q1 2017 from the same period last year, while for Oct 2017 it was -$9.6 million, marking a year-over-year decrease of 75506.85%. This contributed to the annual value of -$53.4 million for FY2025, which is 4924.99% down from last year.
  • According to the latest figures from Q1 2017, KalVista Pharmaceuticals' Other Operating Expenses is -$9.6 million.
  • KalVista Pharmaceuticals' 5-year Other Operating Expenses high stood at $3.8 million for Q4 2014, and its period low was -$9.6 million during Q1 2017.
  • For the 4-year period, KalVista Pharmaceuticals' Other Operating Expenses averaged around -$855800.0, with its median value being $1000.0 (2016).
  • Data for KalVista Pharmaceuticals' Other Operating Expenses shows a peak YoY increase of 10002.61% (in 2015) and a maximum YoY decrease of 10002.61% (in 2015) over the last 5 years.
  • Over the past 4 years, KalVista Pharmaceuticals' Other Operating Expenses (Quarter) stood at $3.8 million in 2014, then plummeted by 100.03% to -$1000.0 in 2015, then surged by 200.0% to $1000.0 in 2016, then tumbled by 956500.0% to -$9.6 million in 2017.
  • Its Other Operating Expenses stands at -$9.6 million for Q1 2017, versus $1000.0 for Q4 2016 and $1.5 million for Q1 2016.